UNSPSC 85513477: Reposition hepatic artery, percutaneous endoscopic approach

This classification denotes the group of activities that yields a surgical intervention or procedure to reposition hepatic artery, percutaneous endoscopic approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 04S34ZZ

UNSPSC 85513477 Reposition hepatic artery, percutaneous endoscopic approach (Commodity) appears in state and local procurement records with no substantive alignment to the code's nominal medical procedure scope. The recent opportunities tagged under this code instead reflect health care administration, pharmacy benefit management, virtual primary care delivery, peer support services for mental health workers, and fire department medical direction — none of which involve hepatic artery repositioning or percutaneous endoscopic surgical procedures. The mismatch suggests either a data-classification error in the underlying procurement system or that the code is being misapplied to administrative health care contracting rather than the specific interventional procedure the code nominally describes.

The issuing bodies in the recent opportunities block span county and city health systems: Muscogee County Prison (Georgia) seeking comprehensive inmate medical and pharmacy services; Collier County (Florida) procuring pharmacy benefit management; Monroe County (Florida) contracting for virtual primary and urgent care; San Mateo County (California) piloting peer support services for peer workers; and Santa Monica Fire Department (California) recruiting a medical director. No repeat buyers appear across the five posted opportunities. Geographic concentration is limited to Florida, Georgia, and California with no clear pattern. Given the absence of procurement activity aligned to the code's stated scope and the fundamental mismatch between the code name and the actual work being solicited, the code shows no actionable signal for business development focused on hepatic artery repositioning or related percutaneous endoscopic procedures in the state and local market.